CVS posted earnings of $2.04 a share, ahead of Wall Street’s $1.72 consensus, as the company’s pharmacy sales rose 3.8 percent and retail sales improved 2.3 percent. “We delivered strong first quarter results and improved our outlook for the year,” said CEO Karen Lynch. “We continue to execute on our strategy while simultaneously managing through a pandemic, helping the country on the road to recovery.”